142 related articles for article (PubMed ID: 35598422)
21. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
[TBL] [Abstract][Full Text] [Related]
22. LV
Sahu G; Patra SA; Pattanayak PD; Kaminsky W; Dinda R
Inorg Chem; 2023 May; 62(17):6722-6739. PubMed ID: 37074879
[TBL] [Abstract][Full Text] [Related]
23. Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes.
Ribeiro N; Bulut I; Pósa V; Sergi B; Sciortino G; Pessoa JC; Maia LB; Ugone V; Garribba E; Enyedy ÉA; Acilan C; Correia I
J Inorg Biochem; 2022 Oct; 235():111932. PubMed ID: 35940023
[TBL] [Abstract][Full Text] [Related]
24. Stabilization of oxidovanadium(IV) by organic radicals.
Kundu S; Maity S; Maity AN; Ke SC; Ghosh P
Dalton Trans; 2013 Apr; 42(13):4586-601. PubMed ID: 23353872
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
[TBL] [Abstract][Full Text] [Related]
26. Chemistry of Monomeric and Dinuclear Non-Oxido Vanadium(IV) and Oxidovanadium(V) Aroylazine Complexes: Exploring Solution Behavior.
Dash SP; Majumder S; Banerjee A; Carvalho MF; Adão P; Pessoa JC; Brzezinski K; Garribba E; Reuter H; Dinda R
Inorg Chem; 2016 Feb; 55(3):1165-82. PubMed ID: 26789655
[TBL] [Abstract][Full Text] [Related]
27. Cu(ii) and V(iv)O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)-l-alanines reveal promising anticancer therapeutic potential.
Ribeiro N; Bulut I; Cevatemre B; Teixeira C; Yildizhan Y; André V; Adão P; Pessoa JC; Acilan C; Correia I
Dalton Trans; 2021 Jan; 50(1):157-169. PubMed ID: 33290472
[TBL] [Abstract][Full Text] [Related]
28. A study of DNA/BSA interaction and catalytic potential of oxidovanadium(v) complexes with ONO donor ligands.
Dash SP; Panda AK; Dhaka S; Pasayat S; Biswas A; Maurya MR; Majhi PK; Crochet A; Dinda R
Dalton Trans; 2016 Nov; 45(45):18292-18307. PubMed ID: 27805190
[TBL] [Abstract][Full Text] [Related]
29. V
Sanna D; Ugone V; Sciortino G; Buglyó P; Bihari Z; Parajdi-Losonczi PL; Garribba E
Dalton Trans; 2018 Feb; 47(7):2164-2182. PubMed ID: 29327005
[TBL] [Abstract][Full Text] [Related]
30. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
[TBL] [Abstract][Full Text] [Related]
31. Characterization and biotransformation in the plasma and red blood cells of V(IV)O(2+) complexes formed by ceftriaxone.
Sanna D; Fabbri D; Serra M; Buglyó P; Bíró L; Ugone V; Micera G; Garribba E
J Inorg Biochem; 2015 Jun; 147():71-84. PubMed ID: 25601642
[TBL] [Abstract][Full Text] [Related]
32. Complexes of copper(II) with tetradentate S,O-ligands: Synthesis, characterization, DNA/albumin interactions, molecular docking simulations and antitumor activity.
Živanović AS; Bukonjić AM; Jovanović-Stević S; Bogojeski J; Ćoćić D; Bijelić AP; Ratković ZR; Volarević V; Miloradović D; Tomović DL; Radić GP
J Inorg Biochem; 2022 Aug; 233():111861. PubMed ID: 35599165
[TBL] [Abstract][Full Text] [Related]
33. New copper(II) and oxidovanadium(IV) complexes with a vitamin B
Balsa LM; Ferretti V; Sottile M; Nunes P; Costa Pessoa J; Correia I; León IE
Dalton Trans; 2024 Feb; 53(7):3039-3051. PubMed ID: 38111362
[TBL] [Abstract][Full Text] [Related]
34. New V
Banerjee A; Dash SP; Mohanty M; Sahu G; Sciortino G; Garribba E; Carvalho MFNN; Marques F; Costa Pessoa J; Kaminsky W; Brzezinski K; Dinda R
Inorg Chem; 2020 Oct; 59(19):14042-14057. PubMed ID: 32914971
[TBL] [Abstract][Full Text] [Related]
35. Implications of Protein Interaction in the Speciation of Potential V
Ferraro G; Paolillo M; Sciortino G; Pisanu F; Garribba E; Merlino A
Inorg Chem; 2023 May; 62(21):8407-8417. PubMed ID: 37195003
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of vanadium complexes with 1,10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cells.
Nunes P; Correia I; Cavaco I; Marques F; Pinheiro T; Avecilla F; Pessoa JC
J Inorg Biochem; 2021 Apr; 217():111350. PubMed ID: 33477088
[TBL] [Abstract][Full Text] [Related]
37. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterization of V(IV)O complexes of picolinate and pyrazine derivatives. Behavior in the solid state and aqueous solution and biotransformation in the presence of blood plasma proteins.
Koleša-Dobravc T; Lodyga-Chruscinska E; Symonowicz M; Sanna D; Meden A; Perdih F; Garribba E
Inorg Chem; 2014 Aug; 53(15):7960-76. PubMed ID: 25013935
[TBL] [Abstract][Full Text] [Related]
39. Reactions of the cationic zinc thiolate model complex [Zn(Tab)4](PF6)2 with N-donor ligands and cobalt dichloride.
Zheng AX; Si J; Tang XY; Miao LL; Yu M; Hou KP; Wang F; Li HX; Lang JP
Inorg Chem; 2012 Oct; 51(19):10262-73. PubMed ID: 22985442
[TBL] [Abstract][Full Text] [Related]
40. A half-sandwich Ta
Trávníček Z; Štarha P; Čajan M; Dvořák Z
Acta Crystallogr C Struct Chem; 2019 Mar; 75(Pt 3):248-254. PubMed ID: 30833518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
